One of the big changes just like everywhere else in healthcare is integration. It is all open source software and using some nice Web 2.0 applications and now includes a dashboard for easy management and locating program modules and relative information. BD The National Cancer Institute for...
This is a real interesting merger with a biotech company patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system merging with a company that provides personal health records, both companies from California. Favrille is involved in clinical trials...
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-02-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
The new vaccine, Lucanix, is genetically engineered to also trick the cancer into turning off its immune system-suppressing activities, this is a turn in a different direction here where vaccines are normally increase the immune system capabilities. The project is enrolling 700 patients at 90 centers...
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-19-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
This is a very small clinical trial of 12 individuals with cancer, and any related treatment plans are still quite a few miles away, but more work with personalized medicine in progress. BD This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment...
This procedure is not approved for us in the US. It is not inexpensive either at 25-30K per procedure, but good money for the physicians getting paid from 5-7k for their work. There are opinions on both sides of the fence and like anything else today, there has not been one cure all that works...
Right now according to the Wall Street Journal, patients who have enjoyed an open relationship are worried that this could all change under management from Roche. Is bigger always better? Recently in the news Genentech is not happy with the offer and may hold out for more. Anyone that...
This is one tough subject by all means. Yes, consumers want early access, but on the other hand if there’s not enough information regarding issues such as side effects, a drug could in fact hasten the process with individuals dying sooner, again studies are what is needed to be safe. ...
The focus for the new facility will be cancer drugs and research. The hopes here are to provide a link between formulation and commercial manufacturing, in essence better availability to be created for patient accessibility related to clinical trials. BD ABBOTT PARK, Ill., June 12 -- Today...